Amass, Leslie <br/><br/>
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.  [electronic resource] 

 -  The American journal on addictions  2004 
 - S42-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1055-0496 
<br/><br/><label>Standard No.: </label>10.1080/10550490490440807  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Sublingual<br/>Adult<br/>Buprenorphine--adverse effects<br/>Community Health Services<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Approval--legislation & jurisprudence<br/>Drug Therapy, Combination<br/>Humans<br/>Male<br/>Middle Aged<br/>Multicenter Studies as Topic<br/>Naloxone--adverse effects<br/>Narcotic Antagonists--adverse effects<br/>Narcotics--adverse effects<br/>National Institutes of Health (U.S.)<br/>Opioid-Related Disorders--rehabilitation<br/>Randomized Controlled Trials as Topic--legislation & jurisprudence<br/>Rehabilitation Centers<br/>Substance Withdrawal Syndrome--drug therapy<br/>Time Factors<br/>United States